Recruiting
Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)
NCT07496229
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
- Henan Provincial People's Hospital Zhengzhou, Henan, China